PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS.

PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS. Meeting Abstract

publication date

September 1, 2019

webpage

Web of Science

published in

FERTILITY AND STERILITY Journal

start page

E4

end page

E4

volume

112

issue

3